ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PRAI Pra Intl Common Stk (MM)

0.00
0.00 (0.00%)
After Hours
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Type
Pra Intl Common Stk (MM) NASDAQ:PRAI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

PRA International to Present Audioconference on Oncology Research - Nov. 8

23/10/2007 6:00pm

PR Newswire (US)


Pra (NASDAQ:PRAI)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Pra Charts.
PRA Oncology Expert to Speak RESTON, Va., Oct. 23 /PRNewswire-FirstCall/ -- PRA International (NASDAQ:PRAI) today announced that Dr. Ute Berger, the company's senior director of therapeutic expertise and a specialist in oncology and hematology, will present a one-hour audioconference on conducting global clinical research in oncology on Thursday, Nov. 8, 2007 at 11:30 a.m. EST. In "Challenges in Conducting Global Oncology Trials," Dr. Berger will recommend ways to mitigate risk in terms of timelines and costs. The audioconference will be of special interest to leaders in pharmaceutical and biotechnology research and development, clinical development, operations, clinical studies, outsourcing, procurement, and global data management. The registration fee is US$199 per phone line. For more information and to register, go to http://www.fxtrans.com/resources/ac/future/ac20071108.htm. The speaker earned her medical degree from Germany's University of Heidelberg where she has served in senior positions on the Faculty of Clinical Medicine for nearly 20 years. Dr. Berger holds medical certifications in internal medicine, oncology and hematology, and is certified by the European Society of Medical Oncology. She has held numerous high-visibility positions, including as medical coordinator for the German CML Study Group, general manager of the German Competence Network "Acute and Chronic Leukemias" and scientific network manager of the "European LeukemiaNet." Dr. Berger has established relationships with key opinion leaders in the hematology/oncology field around the world. Widely published, she is known for her expertise in clinical research and has significant experience overseeing, directing and implementing global oncology trials in a variety of indications. The audioconference is presented in cooperation with ForeignExchange Translations, Inc., the leader in providing linguistic services to medical device, pharmaceutical and biotech companies. About PRA International PRA International is one of the world's leading global clinical development organizations, with over 2,700 employees working from offices in North America, Europe, Asia, South America, Africa and Australia. PRA is committed to delivering reliable service, program-level therapeutic expertise, easy, global access to knowledge and an involved senior management. To learn more about PRA International, please visit http://www.prainternational.com/ or call our World Headquarters at +1 (703) 464-6300. DATASOURCE: PRA International CONTACT: Cynthia Rosso, Marketing Manager of PRA International, +1-703-464-6354, Web site: http://www.prainternational.com/ http://www.fxtrans.com/resources/ac/future/ac20071108.htm

Copyright

1 Year Pra Chart

1 Year Pra Chart

1 Month Pra Chart

1 Month Pra Chart

Your Recent History

Delayed Upgrade Clock